3P BIOTECH NORWAY AS: årsregnskap 2025 vs 2024
Stronger earnings
approved 2026-07-13; registry 2026-07-23; journal 2026 709940
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for 3P BIOTECH NORWAY AS. Net result -53.1k NOK → -13.6k NOK. Equity 205.7k NOK → 192.1k NOK.
On the constructive side: operating result improved; net result improved; cash rose. Pressures included: equity eroded.
Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
What improved
-
↑
Operating result improved
Operating result -68.0k NOK → -17.1k NOK. Calculated
-
↑
Net result improved
Net result -53.1k NOK → -13.6k NOK. Calculated
-
↑
Cash rose
Bank deposits 449 NOK → 450.4k NOK (+100222.7% YoY). Calculated
What deteriorated
-
↓
Equity eroded
Book equity 205.7k NOK → 192.1k NOK. Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is 5.8% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation